Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2014

01-10-2014 | Clinical trial

Diagnostic accuracy of tactile imaging in selecting patients with palpable breast abnormalities: a prospective comparative study

Authors: Marios-Konstantinos Tasoulis, Konstantinos E. Zacharioudakis, Nikitas G. Dimopoulos, Dimitri J. Hadjiminas

Published in: Breast Cancer Research and Treatment | Issue 3/2014

Login to get access

Abstract

Unnecessary referrals of patients with breast lumps represent a significant issue, since only a few patients actually have lumps when examined by a breast specialist. Tactile imaging (TI) is a novel modality in breast diagnostics armamentarium. The aim of this study was to assess TI’s diagnostic performance and compare it to clinical breast examination (CBE). This is a prospective, blinded, comparative study of 276 consecutive patients. All patients underwent conventional imaging and tissue sampling if either a radiological or a palpable abnormality was present. Sensitivity, specificity and positive and negative predictive values for CBE and TI were calculated. Radiological findings and final diagnosis based on histology and/or cytology were used as reference standards. Receiver operator characteristic (ROC) curve analysis was also performed for each method. Sensitivity and specificity of TI in detecting radiologically proven abnormalities were 85.5 % and 35 %, respectively. CBE’s sensitivity was 80.3 % and specificity 76 %. In detecting a histopathological entity according to histology/cytology, sensitivity was 88.2 % for TI and 81.6 % for CBE. Specificity was 38.5 % and 85.7 % for TI and CBE, respectively. These results suggest a trend towards higher sensitivity of TI compared to CBE but significantly lower specificity. Subgroup analysis revealed superior sensitivity of TI in detecting a histological entity in pre-menopausal women. However, CBE’s overall performance was superior compared to TI’s according to ROC curve analysis. Although further research is necessary, the use of TI by the primary care physician as a selection tool for referring patients to a breast specialist should be considered especially in pre-menopausal women.
Literature
1.
go back to reference Smith RA, Duffy SW, Tabar L (2012) Breast cancer screening: the evolving evidence. Oncology 26(5):471–475, 479–481, 485–486 Smith RA, Duffy SW, Tabar L (2012) Breast cancer screening: the evolving evidence. Oncology 26(5):471–475, 479–481, 485–486
3.
go back to reference Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, Lynge E, Euroscreen Working G (2012) Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen 19(Suppl 1):33–41. doi:10.1258/jms.2012.012080 PubMedCrossRef Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, Lynge E, Euroscreen Working G (2012) Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen 19(Suppl 1):33–41. doi:10.​1258/​jms.​2012.​012080 PubMedCrossRef
4.
go back to reference Barton MB, Harris R, Fletcher SW (1999) The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 282(13):1270–1280PubMedCrossRef Barton MB, Harris R, Fletcher SW (1999) The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 282(13):1270–1280PubMedCrossRef
5.
go back to reference Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J (2003) Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen 10(1):16–21PubMedCrossRef Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J (2003) Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen 10(1):16–21PubMedCrossRef
6.
go back to reference Bobo J, Lee N (2000) Factors associated with accurate cancer detection during a clinical breast examination. Ann Epidemiol 10(7):463PubMedCrossRef Bobo J, Lee N (2000) Factors associated with accurate cancer detection during a clinical breast examination. Ann Epidemiol 10(7):463PubMedCrossRef
7.
go back to reference Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 76(1):73–81PubMedCrossRef Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 76(1):73–81PubMedCrossRef
9.
go back to reference Baines CJ, Miller AB, Bassett AA (1989) Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 63(9):1816–1822PubMedCrossRef Baines CJ, Miller AB, Bassett AA (1989) Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 63(9):1816–1822PubMedCrossRef
10.
go back to reference Fletcher SW, O’Malley MS, Bunce LA (1985) Physicians’ abilities to detect lumps in silicone breast models. JAMA 253(15):2224–2228PubMedCrossRef Fletcher SW, O’Malley MS, Bunce LA (1985) Physicians’ abilities to detect lumps in silicone breast models. JAMA 253(15):2224–2228PubMedCrossRef
11.
go back to reference Campbell HS, Fletcher SW, Pilgrim CA, Morgan TM, Lin S (1991) Improving physicians’ and nurses’ clinical breast examination: a randomized controlled trial. Am J Prev Med 7(1):1–8PubMed Campbell HS, Fletcher SW, Pilgrim CA, Morgan TM, Lin S (1991) Improving physicians’ and nurses’ clinical breast examination: a randomized controlled trial. Am J Prev Med 7(1):1–8PubMed
12.
go back to reference Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171–176PubMedCrossRef Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171–176PubMedCrossRef
13.
14.
go back to reference Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, Logvinenko T, Rothschild JG, Graham RA (2013) A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol 20(3):850–855. doi:10.1245/s10434-012-2710-y PubMedCrossRef Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, Logvinenko T, Rothschild JG, Graham RA (2013) A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol 20(3):850–855. doi:10.​1245/​s10434-012-2710-y PubMedCrossRef
16.
go back to reference McDonald S, Saslow D, Alciati MH (2004) Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin 54(6):345–361PubMedCrossRef McDonald S, Saslow D, Alciati MH (2004) Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin 54(6):345–361PubMedCrossRef
17.
go back to reference Saslow D, Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004) Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin 54(6):327–344PubMedCrossRef Saslow D, Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004) Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin 54(6):327–344PubMedCrossRef
18.
go back to reference Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, James M, Knox F, Leidecker V, Woodman C (2002) Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ 324(7336):507PubMedCrossRefPubMedCentral Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, James M, Knox F, Leidecker V, Woodman C (2002) Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ 324(7336):507PubMedCrossRefPubMedCentral
20.
go back to reference Sarvazyan A (1998) Mechanical imaging: a new technology for medical diagnostics. Int J Med Informatics 49(2):195–216CrossRef Sarvazyan A (1998) Mechanical imaging: a new technology for medical diagnostics. Int J Med Informatics 49(2):195–216CrossRef
22.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Standards for Reporting of Diagnostic A (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138(1):40–44PubMedCrossRef Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Standards for Reporting of Diagnostic A (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138(1):40–44PubMedCrossRef
24.
go back to reference Hosseini SM, Kashani SM, Najarian S, Panahi F, Naeini SM, Mojra A (2010) A medical tactile sensing instrument for detecting embedded objects, with specific application for breast examination. Int J Med Robot 6(1):73–82. doi:10.1002/rcs.291 PubMed Hosseini SM, Kashani SM, Najarian S, Panahi F, Naeini SM, Mojra A (2010) A medical tactile sensing instrument for detecting embedded objects, with specific application for breast examination. Int J Med Robot 6(1):73–82. doi:10.​1002/​rcs.​291 PubMed
Metadata
Title
Diagnostic accuracy of tactile imaging in selecting patients with palpable breast abnormalities: a prospective comparative study
Authors
Marios-Konstantinos Tasoulis
Konstantinos E. Zacharioudakis
Nikitas G. Dimopoulos
Dimitri J. Hadjiminas
Publication date
01-10-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3123-3

Other articles of this Issue 3/2014

Breast Cancer Research and Treatment 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine